Structure-activity relationships of quinolone agents against Mycobacteria: Effect of structural modifications at the 8 position

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 10, 1996, Pages 2363-2368

  Renau, Thomas E ^a,d   Gage, Jeffrey W ^a   Dever, Julie A ^a   Roland, Gregory E ^a   Joannides, E Themis ^a   Shapiro, Martin A ^a   Sanchez, Joseph P ^a   Gracheck, Stephen J ^a   Domagala, John M ^a   Jacobs, Michael R ^b   Reynolds, Robert C ^c  

^a PFIZER INC   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

^d Microcide Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 10144258659     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.10.2363     Document Type: Article

References (27)

1. Bloch, A. B., G. M. Cauthen, I. M. Onorato, K. D. Dansbury, G. D. Kelly, C. R. Driver, and D. E. Snider. 1994. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 271:665-671.
2. Bouzard, D., P. Di Cesare, M. Essiz, J. P. Jacquet, J. R. Kiechel, P. Remuzon, A. Weber, T. Oki, M. Masuyoshi, R. E. Kessler, J. Fung-Tomc, and J. Desiderio. 1990. Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives. J. Med. Chem. 33:1344-1352.
3. Bouzard, D., P. Di Cesare, M. Essiz, J. P. Jacquet, P. Remuzon, A. Weber, T. Oki, and M. Masuyoshi. 1989. Fluoronaphthyridines and quinolones as antibacterial agents. 1. Synthesis and structure-activity relationships of new 1-substituted derivatives. J. Med. Chem. 32:537-542.
4. Chu, D. T. W., P. B. Fernandes, R. E. Maleczka, Jr., C. W. Nordeen, and A. G. Pernet. 1987. Synthesis and structure-activity relationship of 1-aryl-6,8-difluoroquinolone antibacterial agents. J. Med. Chem. 30:504-509.
5. Chung, G. A. C., Z. Aktar, S. Jackson, and K. Duncan. 1995. High-throughput screen for detecting antimycobacterial agents. Antimicrob. Agents Chemother. 39:2235-2238.
6. Cohen, M. A., T. J. Griffin, P. A. Bien, C. L. Heifetz, and J. M. Domagala. 1985. In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteria. Antimicrob. Agents Chemother. 28:766-772.
7. Domagala, J. M. 1994. Structure-activity side-effect relationships for the quinolone antibacterials. J. Antimicrob. Chemother. 33:685-706.
8. 1-substituent in determining the structure-activity relationship. J. Med. Chem. 34:1142-1154.
9. Drlica, K., C. Xu, J.-Y. Wang, R. M. Burger, and M. Malik. 1996. Fluoroquinolone action in mycobacteria: similarity with effects in Escherichia coli and detection by cell lysate viscosity. Antimicrob. Agents Chemother. 40:1594-1599.
10. Egawa, H., T. Miyamato, A. Minamida, Y. Nishimura, H. Okada, H. Uno, and J. Matsumoto. 1984. Pyridonecarboxylic acids as antibacterial agents. 4. Synthesis and antibacterial activity of 7-(3-amino-1-pyrrolidinyl)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine- 3-carboxylic acid and its analogues. J. Med. Chem. 27:1543-1548.
11. Grohe, K., and H. Heitzer. 1987. Cycloaracylierung von enaminen. I. Synthese von 4-chinolon-3-carbonsaueren. Liebigs Ann. Chem., p. 29-37.
12. Heifets, L. B., and R. C. Good. 1994. Current laboratory methods for the diagnosis of tuberculosis, p. 85-110. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
13. Jacobs, R. F. 1994. Multiple-drug-resistant tuberculosis. Clin. Infect. Dis. 19:1-10.
14. Klopman, G., S. Wang, M. R. Jacobs, S. Bajaksouzian, K. Edmonds, and J. J. Ellner. 1993. Anti-Mycobacterium avium activity of quinolones: in vitro activities. Antimicrob. Agents Chemother. 37:1799-1806.
15. Matsumoto, J., T. Miyamoto, A. Minamida, Y. Nishimura, H. Egawa, and H. Nishimura. 1984. Pyridonecarboxylic acids as antibacterial agents. 2. Synthesis and structure-activity relationships of 1,6,7-trisubstituted 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids, including enoxacin, a new antibacterial agent. J. Med. Chem. 27:292-301.
16. Nakashima, M., T. Uematsu, K. Kosuge, H. Kusajima, T. Ooie, Y. Masuda, R. Ishida, and H. Uchida. 1995. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob. Agents Chemother. 39:2635-2640.
17. Narita, H., Y. Konishi, J. Nitta, I. Kitayama, M. Miyazima, Y. Watanabe, A. Yotsuji, and I. Saikawa. 1986. Pyridonecarboxylic acids as antibacterial agents. V. Synthesis and structure-activity relationship of 7-amino-6-fluoro-1-(fluorophenyl)-4-oxo-1,8-naphthyridine-3-carboxylic acids. Yakugaki Zasshi 106:802-807.
18. Renau, T. E., J. P. Sanchez, and J. M. Domagala. The synthesis of 3-bromo-2,4,5-trifluorobenzoic acid and its conversion to 8-bromo quinolonecarboxylic acids. J. Heterocycl. Chem., in press.
19. Renau, T. E., J. P. Sanchez, J. W. Gage, J. A. Dever, M. A. Shapiro, S. J. Gracheck, and J. M. Domagala. 1996. Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7. J. Med. Chem. 39:729-735.
20. Renau, T. E., J. P. Sanchez, M. A. Shapiro, J. A. Dever, S. J. Gracheck, and J. M. Domagala. 1995. Effect of lipophilicity at N-1 on activity of fluoroquinolones against mycobacteria. J. Med. Chem. 38:2974-2977.
21. Sanchez, J. P., A. J. Bridges, R. Busch, J. M. Domagala, R. D. Gogliotti, S. E. Hagen, C. L. Heifetz, E. T. Joannides, J. A. Sesnie, M. A. Shapiro, and D. L. Szotek. 1992. New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk. J. Med. Chem. 35:361-367.
22. Sanchez, J. P., J. M. Domagala, S. E. Hagen, C. L. Heifetz, M. P. Hutt, J. B. Nichols, and A. K. Trehan. 1988. Quinolone antibacterial agents. Synthesis and structure activity relationships of 8-substituted quinolone-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids. J. Med. Chem. 31:983-991.
23. Sanchez, J. P., R. D. Gogliotti, J. M. Domagala, S. J. Gracheck, M. D. Huhand, J. A. Sesnie, M. A. Cohen, and M. A. Shapiro. 1995. The synthesis, structure-activity, and structure-side effect relationships of a series of 8-alkoxy- and 5-amino-H-alkoxyquinolone antibacterial agents. J. Med. Chem. 38:4478-4487.
24. Sesnie, J. C., C. L. Heifetz, E. T. Joannides, T. E. Malta, and M. A. Shapiro. 1990. Comparative phototoxicity of quinolones in a mouse phototolerance model, abstr. 399. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
25. Suto, M. J., J. M. Domagala, G. E. Roland, G. B. Mailloux, and M. A. Cohen. 1992. Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity and antimicrobial activity. J. Med. Chem. 35:4745-4750.
26. Tominka, H.. H. Saito, and K. Sato. 1993. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin. Antimicrob. Agents Chemother. 37:1259-1263.
27. Weltman, A. C., and D. N. Rose. 1994. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital. Arch. Intern. Med. 154:2161-2167.